Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Substance Abuse Therapeutics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Substance Abuse Therapeutics Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Substance Abuse Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Opioid Addiction
    • 1.4.3 Tobacco/Nicotine Addiction
    • 1.4.4 Alcohol Dependence
  • 1.5 Market by Application
    • 1.5.1 Global Substance Abuse Therapeutics Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital & Clinics
    • 1.5.3 Residential (non-hospital)
  • 1.6 Coronavirus Disease 2019 (Covid-19): Substance Abuse Therapeutics Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Substance Abuse Therapeutics Industry
      • 1.6.1.1 Substance Abuse Therapeutics Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Substance Abuse Therapeutics Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Substance Abuse Therapeutics Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Substance Abuse Therapeutics Market Perspective (2015-2026)
  • 2.2 Substance Abuse Therapeutics Growth Trends by Regions
    • 2.2.1 Substance Abuse Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Substance Abuse Therapeutics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Substance Abuse Therapeutics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Substance Abuse Therapeutics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Substance Abuse Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Substance Abuse Therapeutics Players by Market Size
    • 3.1.1 Global Top Substance Abuse Therapeutics Players by Revenue (2015-2020)
    • 3.1.2 Global Substance Abuse Therapeutics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Substance Abuse Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Substance Abuse Therapeutics Market Concentration Ratio
    • 3.2.1 Global Substance Abuse Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Substance Abuse Therapeutics Revenue in 2019
  • 3.3 Substance Abuse Therapeutics Key Players Head office and Area Served
  • 3.4 Key Players Substance Abuse Therapeutics Product Solution and Service
  • 3.5 Date of Enter into Substance Abuse Therapeutics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Substance Abuse Therapeutics Historic Market Size by Type (2015-2020)
  • 4.2 Global Substance Abuse Therapeutics Forecasted Market Size by Type (2021-2026)

5 Substance Abuse Therapeutics Breakdown Data by Application (2015-2026)

  • 5.1 Global Substance Abuse Therapeutics Market Size by Application (2015-2020)
  • 5.2 Global Substance Abuse Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Substance Abuse Therapeutics Market Size (2015-2020)
  • 6.2 Substance Abuse Therapeutics Key Players in North America (2019-2020)
  • 6.3 North America Substance Abuse Therapeutics Market Size by Type (2015-2020)
  • 6.4 North America Substance Abuse Therapeutics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Substance Abuse Therapeutics Market Size (2015-2020)
  • 7.2 Substance Abuse Therapeutics Key Players in Europe (2019-2020)
  • 7.3 Europe Substance Abuse Therapeutics Market Size by Type (2015-2020)
  • 7.4 Europe Substance Abuse Therapeutics Market Size by Application (2015-2020)

8 China

  • 8.1 China Substance Abuse Therapeutics Market Size (2015-2020)
  • 8.2 Substance Abuse Therapeutics Key Players in China (2019-2020)
  • 8.3 China Substance Abuse Therapeutics Market Size by Type (2015-2020)
  • 8.4 China Substance Abuse Therapeutics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Substance Abuse Therapeutics Market Size (2015-2020)
  • 9.2 Substance Abuse Therapeutics Key Players in Japan (2019-2020)
  • 9.3 Japan Substance Abuse Therapeutics Market Size by Type (2015-2020)
  • 9.4 Japan Substance Abuse Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Substance Abuse Therapeutics Market Size (2015-2020)
  • 10.2 Substance Abuse Therapeutics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Substance Abuse Therapeutics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Substance Abuse Therapeutics Market Size by Application (2015-2020)

11 India

  • 11.1 India Substance Abuse Therapeutics Market Size (2015-2020)
  • 11.2 Substance Abuse Therapeutics Key Players in India (2019-2020)
  • 11.3 India Substance Abuse Therapeutics Market Size by Type (2015-2020)
  • 11.4 India Substance Abuse Therapeutics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Substance Abuse Therapeutics Market Size (2015-2020)
  • 12.2 Substance Abuse Therapeutics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Substance Abuse Therapeutics Market Size by Type (2015-2020)
  • 12.4 Central & South America Substance Abuse Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Indivior
    • 13.1.1 Indivior Company Details
    • 13.1.2 Indivior Business Overview and Its Total Revenue
    • 13.1.3 Indivior Substance Abuse Therapeutics Introduction
    • 13.1.4 Indivior Revenue in Substance Abuse Therapeutics Business (2015-2020))
    • 13.1.5 Indivior Recent Development
  • 13.2 Pfizer
    • 13.2.1 Pfizer Company Details
    • 13.2.2 Pfizer Business Overview and Its Total Revenue
    • 13.2.3 Pfizer Substance Abuse Therapeutics Introduction
    • 13.2.4 Pfizer Revenue in Substance Abuse Therapeutics Business (2015-2020)
    • 13.2.5 Pfizer Recent Development
  • 13.3 Alkermes
    • 13.3.1 Alkermes Company Details
    • 13.3.2 Alkermes Business Overview and Its Total Revenue
    • 13.3.3 Alkermes Substance Abuse Therapeutics Introduction
    • 13.3.4 Alkermes Revenue in Substance Abuse Therapeutics Business (2015-2020)
    • 13.3.5 Alkermes Recent Development
  • 13.4 Novartis
    • 13.4.1 Novartis Company Details
    • 13.4.2 Novartis Business Overview and Its Total Revenue
    • 13.4.3 Novartis Substance Abuse Therapeutics Introduction
    • 13.4.4 Novartis Revenue in Substance Abuse Therapeutics Business (2015-2020)
    • 13.4.5 Novartis Recent Development
  • 13.5 Mylan
    • 13.5.1 Mylan Company Details
    • 13.5.2 Mylan Business Overview and Its Total Revenue
    • 13.5.3 Mylan Substance Abuse Therapeutics Introduction
    • 13.5.4 Mylan Revenue in Substance Abuse Therapeutics Business (2015-2020)
    • 13.5.5 Mylan Recent Development
  • 13.6 Cipla
    • 13.6.1 Cipla Company Details
    • 13.6.2 Cipla Business Overview and Its Total Revenue
    • 13.6.3 Cipla Substance Abuse Therapeutics Introduction
    • 13.6.4 Cipla Revenue in Substance Abuse Therapeutics Business (2015-2020)
    • 13.6.5 Cipla Recent Development
  • 13.7 Glenmark
    • 13.7.1 Glenmark Company Details
    • 13.7.2 Glenmark Business Overview and Its Total Revenue
    • 13.7.3 Glenmark Substance Abuse Therapeutics Introduction
    • 13.7.4 Glenmark Revenue in Substance Abuse Therapeutics Business (2015-2020)
    • 13.7.5 Glenmark Recent Development
  • 13.8 Dr. Reddy's Laboratories
    • 13.8.1 Dr. Reddy's Laboratories Company Details
    • 13.8.2 Dr. Reddy's Laboratories Business Overview and Its Total Revenue
    • 13.8.3 Dr. Reddy's Laboratories Substance Abuse Therapeutics Introduction
    • 13.8.4 Dr. Reddy's Laboratories Revenue in Substance Abuse Therapeutics Business (2015-2020)
    • 13.8.5 Dr. Reddy's Laboratories Recent Development
  • 13.9 Teva Pharmaceutical
    • 13.9.1 Teva Pharmaceutical Company Details
    • 13.9.2 Teva Pharmaceutical Business Overview and Its Total Revenue
    • 13.9.3 Teva Pharmaceutical Substance Abuse Therapeutics Introduction
    • 13.9.4 Teva Pharmaceutical Revenue in Substance Abuse Therapeutics Business (2015-2020)
    • 13.9.5 Teva Pharmaceutical Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Substance Abuse Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Substance Abuse Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Indivior
    Pfizer
    Alkermes
    Novartis
    Mylan
    Cipla
    Glenmark
    Dr. Reddy's Laboratories
    Teva Pharmaceutical

    Market segment by Type, the product can be split into
    Opioid Addiction
    Tobacco/Nicotine Addiction
    Alcohol Dependence
    Market segment by Application, split into
    Hospital & Clinics
    Residential (non-hospital)

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Substance Abuse Therapeutics status, future forecast, growth opportunity, key market and key players.
    To present the Substance Abuse Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Substance Abuse Therapeutics are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now